Development of Prodrug 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Benzoate (TG100801): A Topically Administered Therapeutic Candidate in Clinical Trials for the Treatment of Age-Related Macular Degeneration
Palanki, Moorthy S. S., Akiyama, Hideo, Campochiaro, Peter, Cao, Jianguo, Chow, Chun P., Dellamary, Luis, Doukas, John, Fine, Richard, Gritzen, Colleen, Hood, John D., Hu, Steven, Kachi, Shu, Kang, XiVolume:
51
Langue:
english
Journal:
Journal of Medicinal Chemistry
DOI:
10.1021/jm7011276
Date:
March, 2008
Fichier:
PDF, 669 KB
english, 2008